Skip to main content

EGFP-COV E Citations (2)

Originally described in: A comprehensive library of fluorescent constructs of SARS-CoV-2 proteins and their initial characterisation in different cell types.
Miserey-Lenkei S, Trajkovic K, D'Ambrosio JM, Patel AJ, Copic A, Mathur P, Schauer K, Goud B, Albanese V, Gautier R, Subra M, Kovacs D, Barelli H, Antonny B Biol Cell. 2021 Jul;113(7):311-328. doi: 10.1111/boc.202000158. Epub 2021 May 10.
PubMed Journal

Articles Citing EGFP-COV E

Articles
Aggregation potency and proinflammatory effects of SARS-CoV-2 proteins. Costa M, Wang DW, Zhao KD, Yuan L, Krisko A, Li JY, Outeiro T, Li W. Sci Rep. 2025 Aug 4;15(1):28446. doi: 10.1038/s41598-025-10013-1. PubMed
SARS-CoV-2 ORF3a blocks lysosomal cholesterol egress by disrupting VPS39-regulated NPC2 trafficking and BMP metabolism. Goodson BA, Montenegro Vazquez V, Doyle A, Kolaczkowski OM, Liu R, Jia J, Ishida M, Ye C, Kell AM, Bradfute SB, Rosas Lemus M, Wang H, Han X, Pu J. Cell Rep. 2026 Jun 23;45(6):117544. doi: 10.1016/j.celrep.2026.117544. Epub 2026 Jun 13. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.